Dr Charles Chan
Director & Consultant Psychiatrist
MBBS (UNSW), M Psych, FRANZCP, Cert. Forensic Psych.
EXISTING PATIENT
Dr Charles Chan graduated with a Bachelor of Medicine from the University of New South Wales in 2005. He trained in psychiatry at Concord Hospital and Royal Prince Alfred Hospital, and completed psychiatry specialist training through the Royal Australian & New Zealand College of Psychiatry (RANZCP) in 2014. He also graduated with a Master of Psychiatry. He has also completed the advanced certificate of Forensic Psychiatry through the RANZCP.
Conditions Treated
- Attention Deficit Hyperactivity Disorder (ADHD)
- Autism Spectrum Disorder (ASD) - Management Only
- Bipolar Disorder
- Depression
- Anxiety Disorder
- Neurodevelopmental and Neurocognitive disorder
- Obsessive-Compulsive Disorder (OCD)
- Post Traumatic Stress Disorder (PTSD)
- Substance Use Disorder
Appointment Type
- Face to Face Appointment
Age Range
- Accepts patients aged 16 to 65
Languages
- English
- Cantonese
- Mandarin
Working Experience
Dr Charles Chan is an Australian Consultant Psychiatrist with over 20 years of experience across private practice, hospital psychiatry, forensic psychiatry, neurostimulation services, clinical research, medical education, and healthcare innovation.
He completed his Bachelor of Medicine at the University of New South Wales in 2005, followed by psychiatry training at Concord Hospital and Royal Prince Alfred Hospital. He obtained Fellowship with the Royal Australian and New Zealand College of Psychiatrists (RANZCP) in 2014 and additionally holds a Master of Psychiatry and an Advanced Certificate in Forensic Psychiatry from the RANZCP.
Dr Chan has extensive experience across both public and private healthcare systems. He previously worked as a Staff Specialist Psychiatrist within NSW Justice Health & Forensic Mental Health Network, gaining substantial experience at the intersection of psychiatry, forensic systems, and medicolegal practice. He also worked as a Visiting Medical Officer (VMO) Psychiatrist at St John of God Richmond and Burwood Hospitals, managing a broad range of psychiatric conditions across inpatient and outpatient settings.
Alongside his clinical work, Dr Chan has maintained longstanding involvement in psychiatric research, medical education, digital health, and healthcare systems innovation. He previously worked as a Consultant Research Psychiatrist at the Brain and Mind Centre (University of Sydney), contributing to research involving mood disorders, sleep disorders, ketamine therapies, and translational psychiatry.
Over the years, Dr Chan has been involved in teaching medical students at the University of Sydney. His selected publications can be found here: https://mindoasis.com.au/invited-talks-of-dr-charles-chan/
Membership & Affiliations
He is also a member of the Australian ADHD Professionals Association (AADPA), reflecting his commitment to evidence-based multidisciplinary care in ADHD management.
He has completed RANZCP-endorsed Transcranial Magnetic Stimulation (TMS) training and was previously an active member of the TMS Committee at St John of God Burwood Hospital. He has also been involved with the MED Black Dog CARE Network, focusing on optimisation of advanced treatment options including TMS and esketamine therapies for complex psychiatric presentations.
Special Interest
Clinically, Dr Chan has specialist interests in:
- Neurodevelopmental disorders including ADHD and Autism Spectrum Disorder
- Mood and anxiety disorders
- Post-traumatic stress disorder (PTSD)
- Treatment-resistant psychiatric illness
- Advanced psychiatric therapies including TMS and esketamine
- Complex longitudinal psychiatric management
- Forensic and medicolegal psychiatry
Dr Chan has completed comprehensive training in Autism Spectrum Disorder assessment and management, including ADOS-2 and ADI-R assessments.
Dr Chan is also a regular invited speaker, providing education to healthcare professionals and the broader community on ADHD, neurodevelopmental disorders, digital psychiatry, and emerging mental health technologies.